Optimi Health (TSE:OPTI) has released an update.
Optimi Health Corp., a GMP psychedelics pharmaceutical manufacturer, has successfully shipped its first batch of MDMA to Israel and secured vital Canadian export authorizations, marking a significant expansion in its global operations. The move enhances the company’s ability to supply controlled substances for scientific and therapeutic use worldwide. Additionally, Optimi has engaged Oak Hill Financial Inc. to strengthen investor relations and promote its corporate milestones within the investment community.
For further insights into TSE:OPTI stock, check out TipRanks’ Stock Analysis page.
